Cancer has been the leading cause of deaths across the globe. Limited efficacy of conventional […]
Cancers are the abnormal growth of cells (mass or tumour) in the body mostly caused […]
The findings of an open-label, single-arm, phase II study published in Onco Targets and Therapy […]
Combined use of ramucirumab and gemcitabine significantly improved overall survival following first-line standard chemotherapy, thus […]
